Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

A mother says years of painful headaches and speech issues from brain tumors were caused by prolonged use of a Pfizer birth ...

Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

But the incumbents look set to fight to hold on to the market, with Alnylam Pharmaceuticals sharing early-phase data on its ...

MedGenome: Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both ...

A U.S. stock rally fueled by Donald Trump’s election victory is stumbling, as investors contend with everything from renewed ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for ...

“ [Trump’s plans] will come at the expense of potentially larger budget deficits, potentially larger debt and there is also ...